GeneNews partners to sell ColonSentry in China
May 19, 2010 by leonardzehr · Leave a Comment
GeneNews (TSX:GEN) signed a binding term sheet with GeneDiagnostics, a private clinical research and services company in China, for the non-exclusive rights to market ColonSentry, the world’s first blood-based test to determine a person’s current risk for colorectal cancer. GeneNews expects negotiations will lead to a formal marketing partnership agreement by the end of June. [...]
Listen to BioTuesdays 
